Literature DB >> 8611637

Analysis of the T-cell activation signaling pathway mediated by tyrosine kinases, protein kinase C, and Ras protein, which is modulated by intracellular cyclic AMP.

T Ohtsuka1, Y Kaziro, T Satoh.   

Abstract

T-cell receptor (TCR) triggering by an anti-CD3 antibody or phytohemagglutinin (PHA) as well as the treatment with phorbol myristate acetate (PMA), a direct activator of protein kinase C (PKC), induces activation of Ras in T-lymphocytes (Downward, J. et al. (1990)) Nature 364, 719-723). In this paper, we studied the role of Ras in the process of TCR-mediated T-cell activation using a human lymphomic Jurkat cell line. The stimulatory effect of TCR cross-linking on Ras activation was inhibited by herbimycin A, a specific inhibitor of protein tyrosine kinases (PTKs), whereas PMA-induced Ras activation was not affected. On the other hand, calphostin C, a specific inhibitor of PKC, blocked not only PMA-induced, but also TCR-mediated formation of Ras.GTP. Furthermore, down-regulation of PMA-sensitive PKC severely impaired the activation of Ras in response to TCR-stimulation. Tyrosine-phosphorylation and translocation to the particulate fraction of phospholipase C-gamma 1 (PLC-gamma 1) were observed upon T-cell activation. Subcellular localization of PKC was also changed when the cells were stimulated with an anti-CD3 antibody or PMA. While TCR-stimulated translocation of PKC was observed only transiently, PMA-induced translocation of PKC was more sustained. These results suggest that the activation of PLC-gamma 1 by PTK and subsequent activation of PKC are important for TCR-mediated Ras activation in Jurkat cells. An activated form of Ras enhanced the activation of interleukin 2 (IL-2) promoter by TCR stimulation or PMA treatment, although the activated Ras by itself was insufficient for IL-2 promoter activation. On the other hand, a dominant-inhibitory Ras diminished almost completely the activation of IL-2 promoter induced by PMA plus calcium ionophore, indicating that Ras is essential for transduction of T-cell activation signals. Cholera toxin (CTX), which directly activates Gs alpha, is shown to inhibit the activation of IL-2 promoter. TCR-mediated Ras activation, tyrosine phosphorylation and translocation of cellular proteins including ZAP-70, PLC-gamma 1 , and PKC. An activated Gs alpha mutant as well as dibutylyl cAMP (dBcAMP) also showed similar inhibitory effects.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8611637     DOI: 10.1016/0167-4889(95)00172-7

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

1.  The Hsp90-specific inhibitor geldanamycin selectively disrupts kinase-mediated signaling events of T-lymphocyte activation.

Authors:  T Schnaider; J Somogyi; P Csermely; M Szamel
Journal:  Cell Stress Chaperones       Date:  2000-01       Impact factor: 3.667

2.  Expansion of CD8+ T cells lacking Sema4D/CD100 during HIV-1 infection identifies a subset of T cells with decreased functional capacity.

Authors:  Emily M Eriksson; Jeffrey M Milush; Emily L Ho; Mariana D Batista; Sara J Holditch; Chris E Keh; Philip J Norris; Sheila M Keating; Steven G Deeks; Peter W Hunt; Jeffrey N Martin; Michael G Rosenberg; Frederick M Hecht; Douglas F Nixon
Journal:  Blood       Date:  2011-12-01       Impact factor: 22.113

Review 3.  Protein kinase C in IL-2 signal transduction.

Authors:  Y Lu; J P Durkin
Journal:  Immunol Res       Date:  1997       Impact factor: 2.829

4.  IL-6 Responsiveness of CD4+ and CD8+ T Cells after Allogeneic Stem Cell Transplantation Differs between Patients and Is Associated with Previous Acute Graft versus Host Disease and Pretransplant Antithymocyte Globulin Therapy.

Authors:  Tor Henrik Anderson Tvedt; Stefan Rose-John; Galina Tsykunova; Aymen Bushra Ahmed; Tobias Gedde-Dahl; Elisabeth Ersvær; Øystein Bruserud
Journal:  J Clin Med       Date:  2022-04-30       Impact factor: 4.964

5.  Phorbol esters and cAMP differentially regulate the expression of CD4 and CD8 in human thymocytes.

Authors:  Hector Martinez-Valdez; Vicente Madrid-Marina; Amos Cohen
Journal:  BMC Immunol       Date:  2002-01-18       Impact factor: 3.615

6.  Sildenafil Citrate Influences Production of TNF-α in Healthy Men Lymphocytes.

Authors:  Michał Zych; Aleksander Roszczyk; Monika Kniotek; Beata Kaleta; Radoslaw Zagozdzon
Journal:  J Immunol Res       Date:  2019-10-22       Impact factor: 4.818

7.  Cell-cell interactions via non-covalent click chemistry.

Authors:  Chad Plumet; Achmet Said Mohamed; Tanguy Vendeuvre; Brigitte Renoux; Jonathan Clarhaut; Sébastien Papot
Journal:  Chem Sci       Date:  2021-06-07       Impact factor: 9.825

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.